| Application no. and date | 18201321.9 (espacenet) (Federated) (European Patent Register), 20150319 | | Patent/reg. no. and date | DK/EP 3450553, 20191225 | | Publication date | 20190306 | | Priority no. and date | US 201461969483 P, 20140324 | | EP pub. no. and date |
EP 3450553 20190306 | | Effective date | | | Applicant/owner | Translate Bio, Inc., 29 Hartwell Avenue
Lexington, MA 02421, US | | Applicant ref. no. | P70662dk01 | | Inventor | DEROSA, Frank, 300 Shire Way
Lexington, MA 02421, US,
HEARTLEIN, Michael, 300 Shire Way
Lexington, MA 02421, US,
CALIAS, Pericles, 300 Shire Way
Lexington, MA 02421, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 48/00 (2006.01) , C12N 15/02 (2006.01) , C12P 21/06 (2006.01) | | Title | MRNA-TERAPI TIL BEHANDLING AF ØJENSYGDOMME | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
